Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Apathy in Parkinson Disease TMS Study

NCT: NCT06087926 · RECRUITING

NCT IDNCT06087926
StatusRECRUITING
Start Date2024-05-01
Completion2027-06-30
SponsorUniversity of North Carolina, Chapel Hill (OTHER)
First posted
Last updated

Brief Summary

The goal of this clinical trial is to develop non-invasive brain stimulation targets for the treatment of apathy, or motivation problems, in Parkinson Disease. The main questions the study aims to answer are: 1. Does transcranial magnetic stimulation change effort task performance in Parkinson's Disease patients? 2. Is there a link between brain signals and apathy? Participants will * complete questionnaires and assessments * perform an effort task * have their brain activity recorded (EEG) * receive non-invasive brain stimulation (TMS) Researchers will compare two stimulation locations (experimental site and control site) to see if TMS of the experimental site has an effect on apathy. Participants will receive stimulation of both sites (during separate visits).

Frequently Asked Questions

What is Apathy in Parkinson Disease TMS Study?

Apathy in Parkinson Disease TMS Study is a clinical trial registered under NCT06087926. Current status: RECRUITING.

What is the status of NCT06087926?

The current status of NCT06087926 (Apathy in Parkinson Disease TMS Study) is: RECRUITING.

When did Apathy in Parkinson Disease TMS Study start?

Apathy in Parkinson Disease TMS Study started on 2024-05-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.